JP2024529185A5 - - Google Patents
Info
- Publication number
- JP2024529185A5 JP2024529185A5 JP2024532367A JP2024532367A JP2024529185A5 JP 2024529185 A5 JP2024529185 A5 JP 2024529185A5 JP 2024532367 A JP2024532367 A JP 2024532367A JP 2024532367 A JP2024532367 A JP 2024532367A JP 2024529185 A5 JP2024529185 A5 JP 2024529185A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- pharmaceutically acceptable
- total weight
- weight
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163230331P | 2021-08-06 | 2021-08-06 | |
| US63/230,331 | 2021-08-06 | ||
| PCT/US2022/039543 WO2023014956A1 (en) | 2021-08-06 | 2022-08-05 | Formulations of radiprodil |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529185A JP2024529185A (ja) | 2024-08-01 |
| JP2024529185A5 true JP2024529185A5 (enExample) | 2025-08-14 |
Family
ID=83189017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532367A Pending JP2024529185A (ja) | 2021-08-06 | 2022-08-05 | ラジプロジルの製剤化 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20250127770A1 (enExample) |
| EP (1) | EP4380547A1 (enExample) |
| JP (1) | JP2024529185A (enExample) |
| KR (1) | KR20240052765A (enExample) |
| CN (1) | CN118019521A (enExample) |
| AU (1) | AU2022323381A1 (enExample) |
| CA (1) | CA3228004A1 (enExample) |
| CO (1) | CO2024002715A2 (enExample) |
| IL (1) | IL310652A (enExample) |
| MX (1) | MX2024001744A (enExample) |
| PE (1) | PE20241385A1 (enExample) |
| WO (1) | WO2023014956A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025137652A2 (en) * | 2023-12-20 | 2025-06-26 | Grin Therapeutics, Inc. | Methods of using radiprodil in the treatment of disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE408611T1 (de) | 2001-07-24 | 2008-10-15 | Richter Gedeon Nyrt | Piperidine als nmda-rezeptorantagonisten |
| JP2011527689A (ja) * | 2008-07-08 | 2011-11-04 | リヒター ゲデオン エヌワイアールティー． | ２−［４−（４−フルオロ−ベンジル）−ピペリジン−１−イル］−２−オキソ−ｎ−（２−オキソ−２，３−ジヒドロ−ベンゾオキサゾール−６−イル）−アセトアミドの結晶形態 |
| AU2009282822A1 (en) * | 2008-08-21 | 2010-02-25 | Richter Gedeon Nyrt. | Methods for treating CNS disorders |
| HUP0900130A3 (en) | 2009-03-03 | 2012-02-28 | Richter Gedeon Nyrt | Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation |
| US8328687B2 (en) | 2010-07-09 | 2012-12-11 | Ford Global Technologies, Llc | Method for controlling an engine that may be automatically stopped |
-
2022
- 2022-08-05 PE PE2024000212A patent/PE20241385A1/es unknown
- 2022-08-05 MX MX2024001744A patent/MX2024001744A/es unknown
- 2022-08-05 JP JP2024532367A patent/JP2024529185A/ja active Pending
- 2022-08-05 US US18/681,382 patent/US20250127770A1/en active Pending
- 2022-08-05 CA CA3228004A patent/CA3228004A1/en active Pending
- 2022-08-05 AU AU2022323381A patent/AU2022323381A1/en active Pending
- 2022-08-05 CN CN202280060141.5A patent/CN118019521A/zh active Pending
- 2022-08-05 IL IL310652A patent/IL310652A/en unknown
- 2022-08-05 EP EP22764500.9A patent/EP4380547A1/en active Pending
- 2022-08-05 KR KR1020247007585A patent/KR20240052765A/ko active Pending
- 2022-08-05 WO PCT/US2022/039543 patent/WO2023014956A1/en not_active Ceased
-
2024
- 2024-03-04 CO CONC2024/0002715A patent/CO2024002715A2/es unknown
-
2025
- 2025-10-31 US US19/376,486 patent/US20260053786A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022141701A5 (enExample) | ||
| EP2760821B1 (en) | Choline salt of an anti-inflammatory substituted cyclobutenedione compound | |
| JP6875407B2 (ja) | Ｊａｋキナーゼ阻害剤またはその薬剤的に許容される塩を含有する医薬組成物 | |
| JP2005518405A5 (enExample) | ||
| JP2022511029A5 (enExample) | ||
| JP2018503611A5 (enExample) | ||
| JP2021525787A5 (enExample) | ||
| JP2025506374A5 (enExample) | ||
| ES2197087T3 (es) | Tabletas tragables con alto contenido de n-acetilcisteina. | |
| JP2024045113A5 (enExample) | ||
| AU2005204014B2 (en) | Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent | |
| KR100681360B1 (ko) | 타액분비 촉진용 카르보스티릴 유도체 | |
| WO2005082330A2 (en) | Co-precipitated amorphous cefditoren pivoxil and dosage forms comprising the same | |
| WO2001019350A1 (en) | Controlled release formulation for administration of an anti-inflammatory naphthalene derivative | |
| EP2709596A1 (en) | Effervescent formulations comprising dexketoprofen | |
| JP2010501520A5 (enExample) | ||
| WO2013151518A1 (en) | Capsule formulations comprising ceftibuten | |
| EP0817631A2 (en) | Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases | |
| WO2011141419A1 (en) | Association of the xanthine oxidase inhibitor febuxostat and metformin and use thereof | |
| WO2012060786A2 (en) | Cefpodoxime proxetil formulations comprising viscosity agent | |
| JP7023600B2 (ja) | シロドシン含有医薬組成物とその製造方法 | |
| CA2286904A1 (en) | Pharmaceutical tablet of amiodarone salt | |
| JP5303605B2 (ja) | サリチル酸類含有経口組成物 | |
| WO2013100879A1 (en) | Pharmaceutical compositions comprising quetiapine | |
| RU2811593C1 (ru) | Фармацевтическая композиция, включающая эзомепразол (варианты), пероральная лекарственная форма на основе фармацевтической композиции, включающей эзомепразол, способ получения и применение пероральной лекарственной формы на основе фармацевтической композиции, включающей эзомепразол |